Other Rules - Recently Adopted Rulemaking Archives

*free viewer or to request a hard copy

Department of Health and Human Services-General; Chapter 275-Reporting and Fee Requirements for Pharmaceutical Manufacturers and Labelers, Section 1-Prescription Drug Clinical Trial Reporting, Section 2-Reporting of Prescription Drug Marketing Costs and S WORD  PDF 
Concise Summary: This adopted rule repeals 26-239 Office of the Attorney General Chapter 111, Reporting Requirements for Pharmaceutical Manufacturers and Labelers, and Department of Health and Human Services Chapter 275, Section 1-Prescription Drug Clinical Trial Reporting, Section 2-Reporting of Prescription Drug Marketing Costs and Section 3-Fee Provision to implement Prescription Privacy Laws. The 125th Maine Legislature enacted PL 2007 on June 29, 2011, which repealed the statutory provisions that authorized the Department to require marketing and clinical drug trial reporting and supported the Attorney General’s position in adopting clinical drug trial reporting requirements as a trade practice. In addition, the federal District Court rendered a decision that the Maine prescription drug privacy statutory provision is unconstitutional, following a recent Supreme Court decision.
Effective Date: February 14, 2012
View Comments: WORD  Posted: February 15, 2012
 
MaineCare Benefits Manual, Ch104 Sec 5, Health Insurance Purchase Option-& Repeal of Ch VIII, Sec 2 WORD   
Concise Summary: The Department of Health and Human Services, MaineCare Services, is deleting a section of the MaineCare Benefits Manual, Chapter VIII, Section 2, and creating a new section of the Maine State Services Manual. Concurrent to this rulemaking, the Office of Integrated Access and Support is adding the eligibility portion of this program and publishing the information in a manual maintained by that Office. The benefits of this State administered program have not changed.
Effective Date: September 15, 2010
View Comments: WORD  Posted: October 15, 2010
 
10-144 Ch 115-Principles of Reimbursement for Residential Care- Room and Board Word   
Concise Summary: In this rulemaking, the Department is changing Chapter 115, Section 20, Fixed /Capital Costs to make the language consistent with language in State statute regarding depreciation recapture for nursing facilities. The change is for this section only. It makes the regulation for residential care facilities consistent with the regulation for nursing facilities in this aspect. The regulation defines how recapture depreciation is calculated upon the sale of a facility. It will add clarity upon the occasions when there are sales of buildings housing both Residential Care and Nursing Care.
Effective Date: 2010-05-01
View Comments: Word  Posted: April 26, 2010
 
Maine State Services Manual, 10-144, Chapter 104, Section 4, Maine Part D Wrap Benefits Word    
Concise Summary: Effective January 1, 2010, the Department is adopting this Emergency rule to increase the member co-payment for generic drugs under the Part D Wrap Benefits from $2.40 to $2.50 per prescription. The co-pay increase is necessary in order to comply with the federal adjustments to copayment requirements under 42 U.S.C. 1395w-102(b). The Department will propose rules that will make the change permanent.
Effective Date: 2010-04-01
View Comments: Word   Posted: March 26, 2010
 
Chapter 275-Reporting Requirements for Pharmaceutical Manufacturers and Labelers; Office of the Attorney General, 26-239, Chapter 111, Reporting Requirements for Pharmaceutical Manufacturers and Labelers Word   
Concise Summary: This letter gives notice of a final rule: Department of Health and Human Services, 10-144, Chapter 275-Reporting Requirements for Pharmaceutical Manufacturers and labelers; Office of the Attorney General, 26-239, Chapter 111, Reporting Requirements for Pharmaceutical Manufacturers and Labelers. This final rulemaking clarifies Maine requirements for clinical trial registration and results reporting, compatible with current and anticipated Federal reporting requirements and with the capabilities of the publicly funded website, www.ClinicalTrials.gov. The rule modifies the scope of the trials required to be registered and reported. It includes requirements to report on observational studies and clarifies the requirements of reporting post hoc analysis of trial results. This rulemaking provides contact information and clarifies the application of penalty for violations. This rule change does not require reposting of previously posted trials. Other minor technical, grammatical and structural changes are included within this rulemaking. This rule change is not anticipated to have any adverse impact on small business.
Effective Date: 2009-11-02
View Comments: Word  Posted: February 5, 2010
 
Chapter 104, Section 4, Maine Part D Wrap Benefits Word  PDF 
Concise Summary: The Department of Heath and Human Services gives notice of a final rule Maine State Services Manual, Chapter 104, Section 4, Maine Part D Wrap Benefits. In order to comply with the federal guidelines that determine the Part D Benefit parameters, the member co-payment for generic drugs has increased from $2.25 to $2.40 per prescription. This rule is required to comply with federal guidelines. The Part D Wrap Benefit covers this co-payment for eligible beneficiaries. The new co-pay amount is reflected in the Appendix to this rule.
Effective Date: 2009-03-29
View Comments: Word  Posted: March 29, 2009
 

 

Recently Adopted Other Rules